SCHEMBL8047458

SCHEMBL8047458

C=C1C(=O)C2=C(OC(C)C2)c2ccc3ccccc3c21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNMT1 P26358 1/20 0.40
CYP19A1 P11511 5/20 0.39
STAT3 P40763 1/20 0.38
ALDH1A1 P00352 4/20 0.36
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
MAPT P10636 3/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
KDM4E B2RXH2 3/20 0.35
LMNA P02545 3/20 0.35
MAPK1 P28482 2/20 0.35
PRKDC P78527 1/20 0.34
HPGD P15428 2/20 0.34
NPSR1 Q6W5P4 1/20 0.34
MAOA P21397 3/20 0.33
MAOB P27338 3/20 0.33
TDP1 Q9NUW8 2/20 0.33
CES2 O00748 1/20 0.33
KDM1A O60341 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3327381 0.88 DNMT1 (0.50) DNMT1CYP19A1STAT3ALDH1A1MEN1
SCHEMBL25704277 0.86 STAT3 (0.45) STAT3KDM4EMAOAMAOBACHE
SCHEMBL8029684 0.82 STAT3 (0.38) STAT3ALDH1A1RAB9AMAOAMAOB
SCHEMBL3327389 0.74 STAT3 (0.50) DNMT1STAT3ALDH1A1MEN1KMT2A
SCHEMBL25704243 0.72 DNMT1 (0.38) DNMT1CYP19A1ALDH1A1MEN1KMT2A
SCHEMBL3334136 0.72 STAT3 (0.43) DNMT1STAT3ALDH1A1MEN1KMT2A
SCHEMBL103969 0.71 STAT3 (0.52) STAT3ALDH1A1MEN1KMT2AMAPT
SCHEMBL8043779 0.71 STAT3 (0.52) STAT3ALDH1A1MEN1KMT2AMAPT
SCHEMBL30662473 0.71 STAT3 (0.52) STAT3ALDH1A1MEN1KMT2AMAPT
SCHEMBL3330784 0.69 STAT3 (0.43) STAT3ALDH1A1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009084835-A2 PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF KIDNEY DISEASES MAZENCE INC. (KR) 2009-07-09 WO disclosed
WO-2008066301-A1 ANTICANCER COMPOSITION CONTAINING NAPHTHOQUINONE-BASED COMPOUND FOR INTESTINE DELIVERY SYSTEM MAZENCE INC. (KR) 2008-06-05 WO disclosed
WO-2008066298-A1 COMPOUND FOR TREATMENT OR PREVENTION OF PROSTATE-RELATED DISEASES AND PHARMACEUTICAL COMPOSITION OF COLON DELIVERY SYSTEM CONTAINING THE SAME MAZENCE INC. (KR) 2008-06-05 WO disclosed
WO-2008066296-A1 PHARMACEUTICAL COMPOSITION CONTAINING PHENANTHRENEQUINONE-BASED COMPOUND FOR INTESTINE DELIVERY SYSTEM MAZENCE INC. (KR) 2008-06-05 WO disclosed
WO-2008066299-A1 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF DISEASES INVOLVING IMPOTENCE MAZENCE INC. (KR) 2008-06-05 WO disclosed